BARDA is continuing its drive to secure more smallpox vaccines, inking another order with manufacturer Bavarian Nordic.
The Danish manufacturer received an order from BARDA for $120 million-worth of its smallpox/mpox vaccine on Thursday. Around $96 million of the contracted vaccines will be manufactured this year but will only partly restore the bulk product used during the mpox outbreak last year.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters